François Diévart, Patrice Darmon, Jean-Michel Halimi, Samy Hadjadj, Denis Angoulvant, Gaétan Prévost, Pierre Delanaye, Jean-Marc Boivin
{"title":"如何以及何时在临床实践中使用iSGLT2(格列酮类):由SFD、SFC、CNCF和SFNDT提出的临床实践共识","authors":"François Diévart, Patrice Darmon, Jean-Michel Halimi, Samy Hadjadj, Denis Angoulvant, Gaétan Prévost, Pierre Delanaye, Jean-Marc Boivin","doi":"10.1684/ndt.2023.25","DOIUrl":null,"url":null,"abstract":"","PeriodicalId":94153,"journal":{"name":"Nephrologie & therapeutique","volume":"19 4","pages":"251-277"},"PeriodicalIF":0.0000,"publicationDate":"2023-08-03","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":"{\"title\":\"[How and when to use iSGLT2 (gliflozins) in clinical practice: a consensus for clinical practice proposed by the SFD, the SFC, the CNCF and the SFNDT].\",\"authors\":\"François Diévart, Patrice Darmon, Jean-Michel Halimi, Samy Hadjadj, Denis Angoulvant, Gaétan Prévost, Pierre Delanaye, Jean-Marc Boivin\",\"doi\":\"10.1684/ndt.2023.25\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"\",\"PeriodicalId\":94153,\"journal\":{\"name\":\"Nephrologie & therapeutique\",\"volume\":\"19 4\",\"pages\":\"251-277\"},\"PeriodicalIF\":0.0000,\"publicationDate\":\"2023-08-03\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Nephrologie & therapeutique\",\"FirstCategoryId\":\"1085\",\"ListUrlMain\":\"https://doi.org/10.1684/ndt.2023.25\",\"RegionNum\":0,\"RegionCategory\":null,\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"2023/7/17 0:00:00\",\"PubModel\":\"Epub\",\"JCR\":\"\",\"JCRName\":\"\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Nephrologie & therapeutique","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.1684/ndt.2023.25","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"2023/7/17 0:00:00","PubModel":"Epub","JCR":"","JCRName":"","Score":null,"Total":0}
[How and when to use iSGLT2 (gliflozins) in clinical practice: a consensus for clinical practice proposed by the SFD, the SFC, the CNCF and the SFNDT].